Pulse Oximeter Accuracy for Hypoxia
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. However, since the study involves healthy participants with no medical problems, it's likely that those on regular medications may not qualify.
What data supports the effectiveness of the treatment Owlet OSS 3.0 for hypoxia?
The research suggests that modern pulse oximeters, like the Owlet OSS 3.0, are generally accurate in measuring oxygen levels even in patients with poor blood flow, especially when placed on the earlobe. This indicates that the Owlet OSS 3.0 may be effective in accurately detecting hypoxia (low oxygen levels in the blood).12345
Is the Owlet OSS 3.0 pulse oximeter safe for use in humans?
Pulse oximeters, including newer models like the Owlet OSS 3.0, are generally safe for use in humans, but their accuracy can vary based on conditions like skin pigmentation and blood flow. They are more accurate when placed on the earlobe and in patients with good blood flow, but may be less reliable in people with darker skin or poor circulation.15678
How does the pulse oximeter treatment for hypoxia differ from other treatments?
The pulse oximeter treatment for hypoxia is unique because it focuses on accurately measuring oxygen levels in the blood, especially during low oxygen conditions, using advanced technology and algorithms. Unlike other treatments that might directly address hypoxia through medication or oxygen therapy, this approach aims to improve the precision of monitoring devices, which is crucial for effective management of the condition.12569
What is the purpose of this trial?
This study tests the accuracy of pulse oximeters in a range of arterial oxygen levels from 100% down to 70%. This is done by comparing the test pulse oximeter readings of young, healthy, adult study participants with blood samples drawn from an artery in the wrist during brief plateaus of progressively lower oxygen saturations. The arterial blood sample is processed in a device called a multi-wavelength hemoximeter and compared to the simultaneous oximeter reading. During each set level of oxygen the participant may be asked to have a motion simulator device apply different types of movement to their hands to assess the pulse oximeter's accuracy during motion. This study will be evaluating the Owlet OSS 3.0 sensor, a component in 2 FDA cleared noninvasive pulse oximeters indicated for infants 1-18 months of age.Testing should require approximately an hour and 15 minutes of the participant's time.
Research Team
Koa Gudelunas
Principal Investigator
Vital Signs Research Group
Eligibility Criteria
This trial is for young, healthy adults. Participants must be able to undergo brief periods of reduced oxygen levels and have blood samples taken from their wrist artery. They should also be comfortable with a motion simulator device being applied to their hands.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo standardized plateaus of oxygen desaturation to evaluate the accuracy of the Owlet noninvasive pulse oximeter during motion and nonmotion conditions
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Owlet OSS 3.0
Find a Clinic Near You
Who Is Running the Clinical Trial?
Owlet Baby Care, Inc.
Lead Sponsor